2nd International BedsidePEWS Day
February 27, 2015
The first International BedsidePEWS Day was held in London, UK in 2014 and highlighted the value of shared knowledge and experience in BedsidePEWS. The 2nd annual International BedsidePEWS Day was held in Toronto, Ontario (Canada) at The Hospital for Sick Children – the birthplace of the Bedside Paediatric Early Warning System.
Inaugural International BedsidePEWS Day
February 27, 2014
The first International BedsidePEWS Day, held in London (UK) in 2014, highlighted the value of shared knowledge and experience with BedsidePEWS.
February 20, 2014
Unfortunately, the harrowing scene of doctors and nurses running with crash carts to a child’s bedside after an ‘unexpected’ code blue is a familiar one to most hospital workers. In 2002 Dr. Christopher Parshuram, a Physician and Safety Scientist in the Department of Critical Care Medicine at The Hospital for Sick Children (SickKids) recognized that in most cases it was possible to identify children well before the immediate call for help was made. With the help of Kristen Middaugh, a paediatric intensive care nurse, he began careful research to see which vital signs could be relied upon to provide early identification of clinical deterioration in children.
Bedside Paediatric Early Warning System (BedsidePEWS™) Earns FDA 510 (k) Approval
Bedside Clinical Systems to bring paediatric care solution to U.S. Hospitals
October 25, 2013
Bedside Clinical Systems (BCS)’s flagship solution, Bedside Paediatric Early Warning System (BedsidePEWS™), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). For the complete BedsidePEWS™ FDA Medical Device listing (K124038), click here.
BedsidePEWS™ tracks a patient’s vital signs, such as heart rate and blood pressure, as part of routine clinical assessments and outputs a single score to indicate the child’s severity of illness. Based on this score, clinicians can mitigate the risk of cardiopulmonary arrest by taking preventive action before or as a child patient’s health begins to deteriorate.
Beyond the clear benefits of preventing unexpected code blue-related deaths in individual patients, by detecting clinical deterioration early BedsidePEWS™ also reduces intra-hospital patient transfers (e.g., admission to critical care and ICU) and the need for rehabilitation from code blue incidents.
FDA 510(k) approval allows BCS to bring our solution to U.S. hospitals and help prevent cardiopulmonary arrest in hospitalized children. With this proven system, we will positively impact the quality and safety of care provided to children, resulting in improved health outcomes. Our vision is to improve paediatric care everywhere: as the only FDA-cleared system, BedsidePEWS will benefit patients, families, and healthcare providers and payers.
The BedsidePEWS™ technology is built on several clinical studies led by Dr. Christopher Parshuram, a paediatric physician and senior scientist at Toronto’s Hospital for Sick Children. Parshuram’s research on the BedsidePEWS™ methodology was validated through a five-year clinical study across four university-affiliated hospitals, demonstrating that BedsidePEWSTM identified patients at risk of a code blue with at least one hour’s notice.
“MaRS Innovation is proud to partner with The Hospital for Sick Children and provide business development and commercialization services to its researchers,” says Dr. Raphael Hofstein, President and CEO. “BCS is one of our earlier start-ups and we are proud and gratified to see their flagship product achieve FDA 501(k) approvals, which demonstrates both the rigour of its science and strength of its intellectual property. BCS is now well positioned to accelerate the pace of healthcare improvements emerging from SickKids in Canada and around the world.”
October 24, 2013
“Courage and creativity are essential for creating a culture of innovation,” Haddad, former CEO of The Hospital of Sick Children, said in her presentation on enabling innovation in children’s health. “SickKids defines innovation as new ways of thinking and doing that imagine a better future and create value for patients, families, funders, staff and society.”
The Bedside Paediatric Early Warning System (BedsidePEWS) can identify children at risk of cardiac arrest with at least one hour’s notice and empowers clinicians by giving them real-time accurate data to make the best care decisions.
Bedside Clinical Systems Achieves ISO 13485:2003 Quality Management System Certification
March 15, 2013
Bedside Clinical Systems (BCS) is proud to announce that it is now certified to the ISO 13485: 2003 standards by the BSI Group, a world leader in implementing best practices to meet the needs of businesses and society. This is an exciting step forward for BCS as ISO 13485 certification is a globally recognized standard for Quality Management Systems. “This is an important milestone in BCS history as it affirms our commitment to our customers to deliver a product that meets the highest quality standards,”” says CEO, Rajesh Sharma. This certification will help BCS bring the Bedside Paediatric Early Warning System (BedsidePEWS™) to hospitals so that they can reduce the amount of unexpected code blue incidents experienced by child patients.
The BedsidePEWS™ solution interfaces with a hospital’s existing Electronic Health Records system to assist clinicians in identifying child patients with deteriorating conditions and those that are at risk of experiencing a code blue event. By providing an early warning with an objective score indicating the patient’s severity of illness, BedsidePEWS™ allows clinicians an opportunity to intervene before a code blue event occurs.
BedsidePEWS™ is the flagship product of BCS. BCS is a company of MaRS Innovation and SickKids Hospital and was created to commercialize decision support innovations from SickKids.